Aeragen
New York, United States · Founded 2021
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Last Round
- Pre-SeedJan 2021
- Rounds
- 1
About
Aeragen is a medical device startup formed out of NYU dedicated to improving the standard of patient care by developing technologies that stop the spread of airborne infectious diseases. The company addresses longstanding issues in hospital, clinic, and EMS environments and beyond. Founded in 2021 under the NYU Technology Opportunities & Ventures program, Aeragen is listed as inactive on the NYU TOV startup portfolio page.
Summary
Aeragen is a Biotech company based in New York, United States, founded in 2021. Its most recent funding was a Pre-Seed round in Jan 2021. Investors include Mount Sinai Innovation Partners.
Funding History
Jan 2021
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aeragen"><img src="https://indexed.vc/api/badge/company/aeragen" alt="Aeragen on Indexed.vc" width="260" height="76" /></a>